Global Sartans Market 2020 Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2026

Global Sartans Market 2020 Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2026

“Global Sartans Market”
WiseGuyReports.com adds “Global Sartans Market Report, History and Forecast 2015-2026” reports to its database

Global Sartans Market

Summary

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Sartans market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5159419-global-sartans-market-report-history-and-forecast-2015

This report also analyses the impact of Coronavirus COVID-19 on the Sartans industry.

Based on our recent survey, we have several different scenarios about the Sartans YoY growth rate for 2020. The probable scenario is expected to grow by a -3.4% in 2020 and the revenue will be US$ 25.0 billion in 2020 from US$ 25.9 billion in 2019. The market size of Sartans will reach US$ 27.2 billion in 2026, with a CAGR of 1.2% from 2020 to 2026.

Sartans are the latest generation of antihypertensive drugs, which have good antihypertensive effect and drug tolerance, less adverse reactions, and have protective effect on target organs, so they are widely used in clinic. There are more than 1 billion patients with hypertension in the world. Long term treatment drives the demand for Sartans and intermediates. Due to the shortage of key intermediates, the tightening of environmental protection and the incident of Sartan impurities, the supply of Sartan products is in short supply and the price continues to rise.

The Sartans can be divided into five categories: Valsartan, Irbesartan, Telmisartan, Losartan and Others. Accordingly, the global market size of Valsartan, Irbesartan, Telmisartan, Losartan and Others will reach US $ xx billion, US $ xx billion, US $ xx billion, US $ xx billion, and US $ xx billion in 2019, respectively, which are increased compared to 2018 xx%, xx%, xx%, xx% and xx%. Valsartan takes a big amount of market with xx%.

 

Valsartan

Valsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination valsartan/hydrochlorothiazide, valsartan/amlodipine, valsartan/amlodipine/hydrochlorothiazide, or valsartan/sacubitril.

 Irbesartan

Irbesartan, sold under the brand name Avapro among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination irbesartan/hydrochlorothiazide.

Telmisartan

Telmisartan, sold under the trade name Micardis among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination telmisartan/hydrochlorothiazide and telmisartan/amlodipine.

Losartan

Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. It is also used for diabetic kidney disease, heart failure, and left ventricular enlargement. It is taken by mouth. It may be used alone or in addition to other blood pressure medication. Up to six weeks may be required for the full effects to occur.

Others

The other sartans contain Azilsartan, Olmesartan, Candesartan, etc.

From the perspective of application, Sartans can be divided into three main categories: Anti-Hypertension, Anti-Viral and Others. Accordingly, the global market size of Anti-Hypertension, Anti-Viral and Others will reach US $ xx billion, US $ xx billion, and US $ xx billion in 2019, respectively, which are increased compared to 2018 xx%, xx% and xx%. Anti-Hypertension takes a big amount of market with xx%.

Anti-Hypertension

Hypertension is one of the most common chronic diseases, and it is also the main risk factor to induce various cardiovascular and cerebrovascular diseases. There are more than 1 billion hypertensive patients in the world, and about 270 million hypertensive adults in China. The treatment of chronic hypertension requires long-term medication, and the huge patient base and long-term treatment demand drive the continuous expansion of the market of antihypertensive drug raw materials and preparations.

Anti-Viral

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Sartans are also used in the antiviral field, among which the more widely used is the treatment of AIDS.

Others

Other applications of Sartans are Anti-Asthma, Anti-Cardiovascular, Anti-Kidney, etc.

Major manufacturers

Table 1.   Major manufacturers and Products Offered

Company

Product Type

Pfizer

Valsartan, Irbesartan, Telmisartan, Losartan

Novartis

Valsartan, Irbesartan, Telmisartan, Losartan

Merck

Valsartan, Irbesartan, Telmisartan, Losartan

AstraZeneca

Valsartan, Irbesartan, Telmisartan, Losartan

Eli Lilly

Valsartan, Irbesartan, Losartan

Sanofi

Valsartan, Irbesartan, Telmisartan, Losartan

Bristol-Myers Squibb

Irbesartan, Telmisartan, Losartan

Bayer

Valsartan, Telmisartan, Losartan

GSK

Irbesartan, Telmisartan, Losartan

Teva Pharmaceutical

Valsartan, Irbesartan, Telmisartan, Losartan

Table 2.   Major manufacturers in China and Products Offered

Company

Product Type

Xianju Pharma

Valsartan, Irbesartan, Telmisartan

Menovo

Valsartan, Irbesartan, Telmisartan, Losartan

Tianyu Pharma

Valsartan, Irbesartan, Telmisartan, Losartan

Starry Pharma

Valsartan, Irbesartan, Telmisartan

Huahai Pharmaceutical

Valsartan, Irbesartan, Telmisartan, Losartan

Table of Contents

1 Sartans Market Overview

2 Global Sartans Market Competition by Company

4 Global Sartans by Application

5 North America Sartans Market Size by Country (2015-2026)

6 Europe Sartans Market Size by Country (2015-2026)

7 Asia-Pacific Sartans Market Size by Country (2015-2026)

8 Latin America Sartans Market Size by Country (2015-2026)

10 Company Profiles and Key Figures in Sartans Business

11 Sartans Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

12 Market Strategy Analysis, Distributors

13 Research Findings and Conclusion

14 Appendix

Continuous…

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

For further information on this report, visit – https://www.wiseguyreports.com/reports/5159418-global-telehealth-systems-key-trends-and-opportunities-to-2026

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/5159419-global-sartans-market-report-history-and-forecast-2015